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http://www.biomedcentral.com/1471-2164/13/696RESEARCH ARTICLE Open AccessDe novo reconstruction of the Toxoplasma gondii
transcriptome improves on the current genome
annotation and reveals alternatively spliced
transcripts and putative long non-coding RNAs
Musa A Hassan1, Mariane B Melo1, Brian Haas2, Kirk D C Jensen1 and Jeroen P J Saeij1*Abstract
Background: Accurate gene model predictions and annotation of alternative splicing events are imperative for
genomic studies in organisms that contain genes with multiple exons. Currently most gene models for the
intracellular parasite, Toxoplasma gondii, are based on computer model predictions without cDNA sequence
verification. Additionally, the nature and extent of alternative splicing in Toxoplasma gondii is unknown. In this
study, we used de novo transcript assembly and the published type II (ME49) genomic sequence to quantify the
extent of alternative splicing in Toxoplasma and to improve the current Toxoplasma gene annotations.
Results: We used high-throughput RNA-sequencing data to assemble full-length transcripts, independently of a
reference genome, followed by gene annotation based on the ME49 genome. We assembled 13,533 transcripts
overlapping with known ME49 genes in ToxoDB and then used this set to; a) improve the annotation in the
untranslated regions of ToxoDB genes, b) identify novel exons within protein-coding ToxoDB genes, and c) report
on 50 previously unidentified alternatively spliced transcripts. Additionally, we assembled a set of 2,930 transcripts
not overlapping with any known ME49 genes in ToxoDB. From this set, we have identified 118 new ME49 genes,
18 novel Toxoplasma genes, and putative non-coding RNAs.
Conclusion: RNA-seq data and de novo transcript assembly provide a robust way to update incompletely
annotated genomes, like the Toxoplasma genome. We have used RNA-seq to improve the annotation of several
Toxoplasma genes, identify alternatively spliced genes, novel genes, novel exons, and putative non-coding RNAs.
Keywords: Toxoplasma, RNA-seq, Trinity, LincRNA, Alternative splicing, TranscriptomeBackground
Toxoplasma gondii is a highly prevalent obligate intra-
cellular protozoan parasite causing disease in immuno-
compromised individuals and congenitally infected
infants. Ten Toxoplasma strains, representing predom-
inant strains in Europe, North and South America [1,2]
and a type II/III recombinant strain [3] have been
sequenced, with the ME49, a type II strain, genome used
as a reference. The Toxoplasma genome, which is pub-
licly available in the Toxoplasma database (ToxoDB), is* Correspondence: jsaeij@mit.edu
1Department of Biology, Massachusetts Institute of Technology, Cambridge,
Massachusetts, USA
Full list of author information is available at the end of the article
© 2012 Hassan et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orapproximately 65Mb, made up of 14 chromosomes, and
8155 genes, with an average of 4.1 introns per gene and
a 52% G / C content [4].
While computational tools such as GlimmerHHM
and TigrScan [5], and TwinScan [6] have been useful
resources for Toxoplasma gene model predictions, dif-
ferences in the algorithms used by these programs have
often resulted in different gene models, leading to uncer-
tainties in the current gene models [7]. Accurately anno-
tated gene models are imperative for genomic research
on Toxoplasma but sufficient genomic data, such as full-
length complementary DNA (cDNA) sequences, is not
available to refine the computationally predicted gene
models. Additionally, even though there are reports ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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is currently unknown what the extent of alternative spli-
cing is in Toxoplasma. Transcript sequence data, such
as expressed sequence tags (ESTs), full-length cDNAs
(FL-cDNAs), and cDNA sequences, provide reliable evi-
dence for resolving gene structures [11] because they de-
fine the intron-exon boundaries and are similar to the
genomic sequence. FL-cDNAs would be ideal for gene
annotation, since they encode the full-length transcript
with well demarcated exon-exon junctions, but the
current cost of Sanger sequencing makes this method
very expensive. Although there is an abundance of
EST and end-sequenced cDNA data (mostly used for
UTR annotations) [4,7,12,13], few FL-cDNA sequence
data is available for Toxoplasma. RNA sequencing
(RNA-seq) [12,14-16] which generates short cDNA
sequences (shorter than ESTs), has become a powerful
tool for gene expression studies and for the de novo as-
sembly of transcriptomes [17-19]. The short sequences
generated by RNA-seq, however, must first be assembled
into full transcript structures using either of two strat-
egies [20,21]: 1) ‘mapping-first’ strategy [22-24], which
involves first aligning the short reads to a reference gen-
ome followed by merging of sequences with overlapping
alignments, and spanning splice junctions, or 2)
‘assembly-first’ (de novo) strategy [17-19], which uses the
reads to directly assemble transcripts that can then be
mapped to a reference genome.
Generally any approach used to reconstruct tran-
scripts from RNA-seq data must be able to navigate
the complications imposed by: i) low expression of
some genes that are in turn represented by low RNA-
seq data thus making them difficult to fully recon-
struct, and ii) short read lengths and alternative
splicing which often makes it hard to correctly match
each isoform with a read [21]. While the ‘mapping
first’ approach is ideal for model organisms with
complete genomes, it still requires correct alignment
of the reads to the reference genome, a fact that is
convoluted by alternative splicing and sequencing
errors. Furthermore, even in well annotated genomes,
like the mouse and human genomes, there are still
novel gene annotations being discovered [23], making
it imprudent to completely rely on currently available
gene structures. Nevertheless, this approach promises
maximal sensitivity and requires less computational
resources compared to the assembly first approach. On
the other hand since the ‘assembly first’ approach does
not require a reference genome, it is well suited for
reconstructing transcripts from organisms with incom-
plete or no annotated genomes. However, besides the
large amount of computational infrastructure required,
the key challenge to this approach is the partitioning
of reads into components representing transcriptisoforms. That is, as the number of reads increases, it
becomes difficult to determine which reads should be
joined into a contiguous contig. However, this prob-
lem has been resolved by the use of the de Bruijn
graph which models overlapping sequences rather
than reads, thereby reducing the complexity of deal-
ing with multiple reads [25-27]. Additionally, by ana-
lyzing the graph paths taken by the reads and read
pairs and applying a coverage cutoff to determine
which path to follow or to remove [18,21], the prob-
lem posed by sequencing errors from variations,
which can make the graph complex by introducing
branching points are easily resolved [21]. Overall,
both of these approaches have been reported to ac-
curately reconstruct several transcripts and alternative
isoforms [23,24,28], therefore, the choice of which
method to use is invariably dependent on the avai-
lability of a well annotated reference genome and the
biological question to be answered.
We sequenced cDNA from polyadenylated RNA
obtained from murine bone marrow derived macro-
phages infected with a type II Toxoplasma strain (Pru).
Because currently there is no annotated genome for
the Pru strain, and the ME49 reference genome is not
complete, we then used Trinity-based de novo tran-
script assembly [18] to reconstruct transcripts from ap-
proximately 270 million RNA-seq reads. Finally, we
used PASA (Program to Assemble Spliced Alignments)
[29-31], and the published ME49 reference genome
(ToxoDB) [4], to filter invalid assemblies and tran-
scripts likely resulting from sequencing errors, and to
reconstruct more complete transcripts. PASA assembles
overlapping and compatible alignments, which are
defined as overlapping alignments transcribed on the
same strand and have identical introns in the regions
of their overlap [31], and is therefore suitable for the
discovery of alternative splicing variants and novel
transcripts. Transcripts derived from de novo assembly
and alignments to a reference genome are reported to
provide a template for genome annotation that com-
pares well with the utility of FL-cDNAs [11]. Using this
hybrid approach (de novo assembly followed by align-
ment to a reference genome), we provide transcript-
based gene structures that we then use to confirm
ToxoDB gene models, update existing UTRs, update
current ToxoDB predicted intron/exon boundaries,
identify new gene models that represent alternatively
spliced isoforms, and identify new genes. In summary,
we have identified 2,930 transcripts not overlapping
with any known ME49 genes; some of which may be
novel genes, or non-coding RNAs. Additionally, we
have identified 50 alternatively spliced transcripts and
report on their differential usage amongst 3 clonal
Toxoplasma strains.
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De novo full-length transcript assembly
Approximately 1.2 billion 40 base-pair (bp) paired-end
RNA-seq reads generated from murine bone-marrow
derived macrophages infected with Toxoplasma were
used to assemble Toxoplasma full-length transcripts in
Trinity [18] and PASA [29,31]. A flow chart of the stepsTrinity transcript assembly
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Figure 1 Schematic of methods used for de novo transcript assembly
used to assemble and annotate Toxoplasma full-length transcripts using RN
multiple categories (i.e. fused genes, changed exons, and changed UTRs) wfollowed to assemble and annotate transcripts is pre-
sented in Figure 1. Because the parasites used to infect
the murine macrophages were grown in human foreskin
fibroblasts (HFFs), we initially used the genome align-
ment tool, Tophat [32,33] to sequentially align the RNA-
seq reads to the mouse (mm9) and human (hg19) reference
genomes and a collection of mouse and human splicePASA clustering
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e highlight only the types of variation observed in the current study.
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Since the two genomes (mouse and human) are almost
complete, about 270 million reads, which did not align
to them, were considered to be mainly Toxoplasma
derived and were used as input for de novo transcript as-
sembly in Trinity (Materials and Methods). In total, we
assembled 29,294 contigs (hereafter referred to as Trinity
contigs).
The transcript assembly strategy employed in Trinity
(detailed in Grabherr et al. [18]) requires Trinity contigs
to be joined only if there is a substantial overlap between
them. Therefore, reads obtained from an alternatively
spliced gene will be assembled into one complete tran-
script and one contig representing the unique region
from the second isoform. Additionally, lowly expressed
genes may not generate enough RNA-seq reads for
complete transcript assembly, particularly for longer
genes. Consequently, the Trinity contigs will be a mix-
ture of complete transcripts (includes one isoform of
each alternatively spliced gene), unique regions of alter-
natively spliced transcripts, and fragments from lowly
expressed genes. Thus, to filter Trinity contigs and iden-
tify alternatively spliced transcripts, we used PASA to as-
semble and cluster them based on the positions they
aligned to in the type II (ME49) Toxoplasma genome.
Following assembly in PASA, 23,898 out of the 29,294
Trinity contigs (81%) had valid ME49 genome align-
ments and were clustered into 16,462 transcripts (hence-
forth PASA transcripts), while 5,396 had invalid
alignments and were excluded from PASA analysis
(Additional files 1, 2, 3 and 4).
A major limitation to both de novo and ab initio tran-
scriptome assembly is that overlapping transcripts can
be joined even though they are not from polycistronic
RNA (reviewed in [35]). For overlapping transcripts
transcribed on opposite strands, this problem can be
mitigated by the use of strand specific RNA-sequencing
[36,37]. However, overlapping transcripts transcribed
from the same strand can only be separated by using
cap- or end-specific RNA-seq [35]. However, amongst
the requirements for valid transcript alignment to the
genome in PASA is that all inferred exon-intron bound-
aries must have consensus splice sites, a requirement
that is unlikely to be met when overlapping UTRs from
two adjacent genes translated on opposite strands are
joined in Trinity to form a spurious intron. Furthermore,
during transcript annotation update in PASA, some
fused transcripts will be rejected if considered to result
in transcripts that are out of frame with the existing
gene structures. Additionally, transcripts can only have
valid alignments in PASA if 90% of their length has 95%
sequence similarity with the ME49 genome. Conse-
quently, we postulated that some of the 5,396 Trinity
contigs that did not have valid alignments to the ME49genome in PASA contain Toxoplasma transcripts that
were erroneously joined in Trinity due to overlapping
UTRs and transcripts that did not meet the 90% length re-
quirement. Indeed when these 5,396 Trinity contigs were
aligned to ME49 proteins using Blastx [38], 749 matched
known ME49 proteins. We envisioned two possible sce-
narios for overlapping genes joined by chance in Trintiy:
a) if two fully assembled transcripts are joined due to
overlapping UTRs the resulting transcript will produce 2
ORFs, each significantly matching either one of the two
overlapping genes, and b) if only one transcript of the
joined pair is completely assembled then it will align to
the protein sequence of only one of the genes. Of the 749
Trinity contigs having significant matches against ME49
genes in Blastx, 95 significantly matched at least 2 adja-
cent ME49 genes (Additional file 5). An example is the
Trinity contig comp489_c0_seq1, which significantly
matched three adjacent genes; Rop18 (TGME49_005250),
TGME49_005240, and TGME49_005230, but produced
only 2 ORFs one matching Rop18 and the other match-
ing TGME49_005240 and TGME49_005230. Thus,
TGME49_005240 and TGME49_005230 seem to be a sin-
gle gene but the 3’UTR of TGME49_005240 gene was er-
roneously joined with the 5’ UTR of Rop18. Indeed
splice junction tracks, supported by RNA-seq data,
available in ToxoDB confirm the existence of a splice
site between the last exon of TGME49_005230 and
the first exon of TGME49_005240 (Additional file 6).
We conclude that these 95 transcripts were errone-
ously joined in Trinity due to an overlap in their
UTRs and were therefore, rejected by PASA. The
rest of the 654 Trinity contigs that aligned to ME49
proteins are Toxoplasma transcripts that were dis-
carded in PASA because they did not meet the 90%
alignment length requirement imposed in PASA. The
other 4,647 Trinity contigs that did not match ME49
genes produced significant matches against mouse
and human bacterial artificial clone (BAC) sequences
available in the NCBI non-redundant nucleotide data-
base, and none mapped to known mouse or human
genes.
We hypothesized that the limiting factor for full-
length transcript assembly is the RNA-seq coverage of
each gene. To test this, we calculated the number of
RNA-seq reads overlapping each full-length PASA tran-
script (we define full-length PASA transcripts in this
case as transcripts translated into proteins with identical
sequence and length to those predicted in ToxoDB) then
binned the PASA transcripts based on RNA-read cover-
age. Because there is a high probability of sequencing
cDNAs from long compared to short transcripts, reads
from longer transcripts tend to be over-represented in
the sequencing data. We correct for this bias by present-
ing coverage as a fraction of transcript length, reads per
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coverage for each PASA transcript (Additional file 7). As
expected, we found that the ability to assemble complete
transcripts was improved with high read coverage of
each gene (Additional file 8).
Identification of novel Toxoplasma genes
Since the Toxoplasma genome annotation is incomplete,
we postulated that some of the PASA transcripts were
putative novel ME49 and Toxoplasma genes (we de-
fine novel ME49 genes as genes already described in
other Toxoplasma strains but not in ME49 and novel
Toxoplasma genes as those yet to be annotated in any
Toxoplasma strain in ToxoDB). Because the PASA
transcripts are annotated based on the region they
aligned to in the ME49 genome, we searched for
PASA transcripts whose genomic coordinates over-
lapped with known ME49 genes in ToxoDB (hereafter
ToxoDB genes) using BEDtools [39]. We confirmed
some of these intersections by simultaneous viewing
of individual PASA transcripts and ToxoDB genes in
the Integrative Genomics Viewer (IGV) [40]. We
identified a total 13,533 PASA transcripts with, and
2,929 PASA transcripts without genomic coordinate
overlap with known ToxoDB genes (Additional file 7).
Approximately, 93% of the 2,929 transcripts were pre-
dicted to be from single exon genes, and 65 (2%)
aligned to sequences on the ToxoDB DS984XXX-
designated scaffolds, corresponding to scaffolds yet to
be assigned to the 14 Toxoplasma chromosomes. Be-
cause the 2,929 transcripts align to the ME49 genome
but do not overlap any known ME49 gene, and have
substantial raw RNA-seq reads pile-up (Figure 2), they
are potentially transcribed from novel genes.
To investigate if any of these PASA transcripts were
indeed novel protein coding transcripts, we performed a
Blastx search against the non-redundant protein data-
base in NCBI (www.ncbi.nih.gov), with an expectationR
PK
M
40
0
20
2039480 2032039644
Genomic coordinate (T
Figure 2 2,930 PASA transcripts did not overlap with any of the curre
Shown is a PASA transcript S2826 (Black) that aligned to a genomic sequen
We also show RNA-seq reads pile-up (histogram represented as reads per k
mapping to the exon-exon junction. This transcript produces an ORF of 14
from the type 1 GT1 strain, but has no homology to any annotated ME49 pcutoff of 10-10. 27 of these transcripts matched known
ME49 proteins and were excluded from potential novel
genes. We postulate that these 27 transcripts may be
novel genes but produce ORFs that are partially identical
to other known ME49 proteins. 212 of the remaining
2902 transcripts had significant matches against other
proteins in the non-redundant NCBI database. Interest-
ingly, the majority of the transcripts, 202, significantly
matched sequences from either Neospora caninum, a
close relative of Toxoplasma, or from other Toxoplasma
strains. 18 transcripts out of the 212 were of the same
length and had identical sequences to proteins already
described in other Toxoplasma strains (VEG and GT1)
indicating that these are genes yet to be annotated in the
ME49 strain (novel ME49 genes); the strain to which we
aligned the PASA transcripts (Additional file 9). While
another 16 transcripts significantly matched Toxoplasma
proteins of the same length in the NCBI database, the
percentage of sequence similarity ranged from 91-99%.
Potentially, these 16 are novel ME49 genes, but unlike
the first 18, are polymorphic between ME49 and the
other Toxoplasma strains. An example of this is a 125
amino acid long protein, which produced two signifi-
cant hits against GT1 (TGGT1_064380) and VEG
(TGVEG_059280) proteins with three mismatches; two
mismatches occurring at positions where the GT1 and
VEG proteins showed polymorphism, and the other
mismatch was at a position where the GT1 and VEG
proteins were homologous. The other proteins that
aligned to Neospora proteins may be proteins yet to be
described in any of the Toxoplasma strain i.e. novel
Toxoplasma genes.
The remaining 2,690 PASA transcripts that produced
no significant Blastx match are unlikely to encode pro-
teins and are potential non-coding RNAs or spurious
transcript assemblies. However, some of these transcripts
could be fragments from novel genes and therefore not
all of them can be regarded as non-coding RNAs.13
9812 2040405 2040568
GME49_chrIV), “+” strand
ntly annotated (ToxoDB) type II (ME49) Toxoplasma genes.
ce on TGME49_chrIV but did not overlap with any of the ME49 genes.
ilobase per million reads or RPKM) on the exons and 13 reads
6 amino acids, which is homologous to the TGGT1_124090 protein
rotein.
Hassan et al. BMC Genomics 2012, 13:696 Page 6 of 13
http://www.biomedcentral.com/1471-2164/13/696Nevertheless, about 80% of PASA transcripts with RPK
values above 900 were fully assembled (Additional file 8).
We therefore, investigated the likelihood of the 2,690
PASA transcripts being pieces of incompletely assembled
novel genes based on their RPK values. Of the 2,690
PASA transcripts, 9 (6 of which have a single exon) had
RPK values above 900 and a minimum length of 200bp
(in mice and humans lincRNAs are defined as non-
coding transcripts longer than 200bp [41,42]). Even
though majority of the 9 transcripts have single exons,
based on the RPK values, these 9 transcripts are likely
to be fully assembled. Because lincRNAs are often
expressed at low levels compared to protein-coding
genes [24,41,43], deeper sequencing might clarify if the
other transcripts are fragments of new genes or are pu-
tative lincRNAs.
Toxoplasma gondii gene model annotation
Following the identification of transcripts overlapping
known ME49 genes, we compared our predicted PASA
gene models and the current ToxoDB gene models. Even
though each PASA transcript overlapping with a ME49
gene is likely transcribed from that gene, some of these
PASA transcripts could be fragments sequenced from
retained introns, misassemblies, antisense transcripts,
misalignments, or non-coding RNAs transcribed from
within known genes. Consequently, to identify which of
the 13,533 PASA transcripts overlapping with known
ME49 genes were protein-coding, we performed a Blastx
search against known ME49 proteins, with an expect-
ation cutoff of 10-10; 9,592 non-redundant PASA tran-
scripts produced significant matches, with 2,073
transcripts producing ORFs of identical length and se-
quence to the protein from the ME49 gene they over-
lapped. The remaining 3,941 did not produce any
significant match and were excluded from further ana-
lysis. It is plausible that the PASA transcripts with no
significant match are fragments from larger genes not
fully reconstructed due to insufficient RNA-seq read
coverage. However, about 9 of these transcripts had RPK
values >900, the level at which about 80% of the tran-
scripts were fully assembled (Additional file 8). Conse-
quently, we propose that some of these transcripts are
putative non-coding RNAs transcribed from within
known Toxoplasma genes, are antisense RNA (aRNA),
are translated on different frames from those used in
predicting ToxoDB proteins, or that some of the cur-
rently predicted ToxoDB genes overlapped by these
PASA transcripts are spurious.
When we compared PASA and ToxoBD gene models,
we found inconsistencies which we classified as follows:
a)Variations in ToxoDB UTRs annotation: Inaccuracies
in the UTRs of annotated ToxoDB genes haspreviously been reported [7]. This set constituted the
majority of variation evidenced between our
predicted models and those available in ToxoDB.
Since computational models, which is the basis for
most of the ToxoDB gene models, are based on the
prediction of coding sequences (CDS) while
transcript-based models rely on the whole RNA,
variations in UTRs between computational and
RNA-seq predicted gene models are expected to
dominate. This set will produce ORFs with identical
sequence and length to the proteins of ToxoDB
transcripts they overlapped, but will have different
gene coordinates due to differences in UTR lengths
(Figure 3a).
b)Fused genes: This category includes transcripts
predicted in PASA to be single genes but are
reported in ToxoDB to be more than one
individual gene. As indicated above, genes
transcribed from the same or opposite strands that
were spuriously joined due to overlapping
UTRs did not pass the PASA filter. Consequently,
the transcripts included in this set are those
that had splice sites at the inferred exon-intron
junctions, had RNA-seq reads supporting the splice
junctions, and were in frame with the annotated
ToxoDB genes that were predicted to be fused.
About 74 transcripts were included in this
category (Figure 3b).
c)ToxoDB genes predicted in PASA to have either
different transcription start sites or novel 5’ exons:
This group includes transcripts which even though
they have ORFs that are identical in sequence
to the protein of the ToxoDB gene they overlap, the
ORFs differ in length from the ToxoDB protein.
Amongst these were transcripts with extra 5’ exons
not predicted in the ToxoDB gene they overlapped,
and transcripts with the same exon counts to the
ToxoDB gene but different 5’ start sites
(Figure 3c).
d)Inaccuracies on the 3’ end sites of ToxoDB genes.
These included ToxoDB genes predicted in PASA to
have extra 3’ exons or different 3’ end sites
(Figure 3d). Like c above, these transcripts produced
ORFs that were identical to the proteins of the
ToxoDB genes they overlapped but were of variable
length either due to a novel 3’ exon or different 3’
end site.
e)Novel exons within predicted ToxoDB genes: We
found transcripts with at least one novel exon in
regions annotated for introns within protein-coding
ToxoDB genes (Figure 3e).
f ) Of the changed ToxoDB genes, we found genes with
fewer or spurious exons compared to the PASA
transcripts (Figure 3f ).
(E)
TGME49_121690
S1038
UTR
(A)
TGME49_025310
S11401
UTR UTR
(B)
TGME49_033750 TGME49_033760
S9628
UTR
(C)
TGME49_071770
S10047
(D)
TGME49_084620
S5259
UTR
(F)
TGME49_025560
S11364
UTR
UTRUTR
UTRUTR
UTR
Figure 3 Refinement of gene models as currently predicted in ToxoDB. (A) A ToxoDB gene (Blue) with discrepancies in the UTRs compared
to the PASA transcript (Black). (B) Two ME49 genes (Blue) are fused into one PASA transcript (Black). (C) A PASA transcript with two novel 5’ exons
lacking in the predicted ME49 gene (Black). (D) A PASA transcript (Blue) with a novel 3’ exon lacking in the ME49 gene (Blue). (E) A PASA
transcript (Blue) with a novel internal exon in a region containing an intron in a ME49 gene (Black). (F) A ME49 gene (Black) with three exons
fused into one in the corresponding PASA transcript (Blue).
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tities of ToxoDB genes grouped into these categories
and that unlike inaccuracies in the UTRs, variations in
the 5’ start and 3’ end sites result in proteins of different
lengths to those predicted in PASA. Additionally, due to
the possibility of some of the PASA transcripts being in-
complete assemblies, we did not investigate longer Tox-
oDB genes that are potentially several genes fused
together (the reverse of “b” above).
Assessing alternative splicing in Toxoplasma gondii
To determine the extent of alternative splicing in Toxo-
plasma, we used the protein-encoding PASA transcripts
overlapping (9,592) and not overlapping (239) with
known ME49 genes. Transcripts were considered to be
splice variants if they aligned to the same genomic locus,
and were transcribed from the same stand. Becausevariants supported by a single RNA-seq read can be due
to sequencing errors, reads from pre-processed RNA,
and errors in transcription, we computed the number of
reads supporting the regions unique to each isoform i.e.
reads supporting the existence of an alternative isoform;
all the remaining variants were supported by at least two
unique reads. In total 77 genes were alternatively spliced,
resulting in 152 transcripts. However, only 50 alterna-
tively spliced genes resulted in different transcript and
protein isoforms (Additional file 10). We did not observe
any unique splicing patterns in the current study with
splicing in Toxoplasma generally taking the forms previ-
ously described in other eukaryotes [44] and included 1)
alternate acceptor (AA), 2) alternate donor (AD), 3) al-
ternate terminal exon (ATE), 4) retained intron (RI), 5)
spliced intron (SI), 6) skipped exon (SE), 7) retained
exon (RE), and 8) initiation within intron (IWI), where
Hassan et al. BMC Genomics 2012, 13:696 Page 8 of 13
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tion of each class is contained in Campbell et al. [31]
and an example of each is presented in Figure 4. In our
data, the majority of the alternative events (40%)
belonged to the AD class. Additionally, because the iso-
form annotation is based on pooling of reads from 27
samples, the distribution of this splice isoforms amongst
the individual samples is not apparent in the current
study.(A) Alternate donor
(C) Retained or spliced intron
(D) Retained or spliced exon
(E) Initiation within an intron
(F) Alternate terminal exons
(B) Alternate acceptor
TGME49_008740
asmbl_812
asmbl_811
UTR
UTR
UTR
TGME49_053370
asmbl_1942
asmbl_1941
TGME49_009570
asmbl_948
asmbl_947
UTR
UTR
UTR
TGME49_014090
asmbl_12398
asmbl_12400
UTR
UTR
TGME49_054440
asmbl_2149
asmbl_2151
UTR
UTR
TGME49_038230
asmbl_5431
asmbl_5432
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UTR
Figure 4 Alternative splicing in Toxoplasma takes similar forms descr
Alternate Donor (A), Alternate Acceptor (B), Retained or Spliced Intron (C),
Alternate Terminal Exons (F). ToxoDB genes are depicted in blue and PASA
observed.The limitation of our method for alternative isoform
discovery is that junction read coverage of some genes
may be insufficient to detect all mRNA isoforms. There-
fore to determine the effect of gene expression level
on the sensitivity of our alternative isoform detection
method, we assessed whether the genes with the highest
read coverage exhibited a frequency of alternative
splicing different from that of genes with lower cover-
age. Briefly, we first identified all single-exon protein-UTR
UTR
UTR
UTR
UTR
UTR
UTR
UTR
UTR
ibed in other eukaryotes. Types of alternative splicing included
Retained or Spliced Exons (D), Initiation Within and Intron (E) and
transcripts in black. Red arrows indicate regions where variation is
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http://www.biomedcentral.com/1471-2164/13/696encoding PASA transcripts; 3,958 were confirmed as sin-
gle exon genes and did not have any alternative isoforms
and were not considered further. The remaining 5,873
set of non-redundant multi-exonic genes was binned
based on read coverage. We then determined the frac-
tion of alternatively spliced genes in each bin
(Figure 5A-B). We found that the ability to detect alter-
natively spliced genes was dependent on expression
level, with alternatively spliced genes significantly
enriched in the top bin (Chi-square p= 0.0001). To dif-
ferentiate major and minor isoforms, we compared their
relative expression levels (Additional file 9) and desig-
nated the most abundant as the major isoform. We ex-
pect that with transcriptomes from different host
infection models, different Toxoplasma growth stages0-3 3-3.5 >3.5
genes
0-2.70 2.70-3.18 >3.18
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Figure 5 The ability to detect alternatively spliced isoforms
using RNA-seq data is dependent on read coverage. Shown are
fraction of alternatively spliced (from a total of 50) (Black bars) and
multi-exonic genes (from a total of 5,873)(Grey bars) identified in
bins (A) grouped by the Log10 of the expression level as reads per
kilobase (RPK) or (B) grouped by the Log10 of raw coverage.
Alternative isoforms are more likely to be detected amongst highly
expressed genes compared to genes with low expression. See also
additional file 9 for the relationship between read coverage and full
assembly of transcripts.(bradyzoites, tachyzoites) and strains, and with higher
RNA-seq read coverage, more alternatively spliced Toxo-
plasma genes will be detected in the future.
Differential isoform usage amongst different
Toxoplasma strains
Differential isoform usage has previously been shown to
be a determinant in disease progression in mice [45],
humans [46], and parasite virulence [8]. Having detected
alternatively spliced genes, we evaluated differential iso-
form usage amongst 3 clonal strains of Toxoplasma preva-
lent in Europe and North America (two type II strains Pru
and ME49 and a type I strain RH) using the mixture-of-
isoforms (MISO) algorithm [47]. MISO leverages the
number of reads aligning to exons and exon junctions,
taking into account the insert lengths for paired-end se-
quencing, to compute the percentage spliced in (PSI)
value, which is the relative fraction of reads supporting
the inclusion isoform [47]. The percentage spliced in (PSI)
values for select genes are presented in Table 1. Based on
the PSI values, there is evidence for alternative isoform
usage by the Toxoplasma strains.
However, because PSI is based on the number of
reads, which varies between samples, the PSI value will
be more informative for each sample and not between
samples. To correct for the variations between samples
when comparing alternative splicing, MISO uses the
Bayes factor to calculate the odds of differential splicing
occurring. We illustrate this by comparing splicing in
Pru and RH strains, two commonly used lab strains
representing type II and type I strains, respectively, and
present a summary of genes, with at least 5 times (Bayes
factor of 5) probability of being spliced in either strain,
together with the corresponding values of reads suppor-
ting each isoform (Table 2). As further evidence for the
presence of the different transcript variants, we show a
piling of RNA-seq reads on a pair of isoforms in Pru
and RH (Figure 6a-b). The alternatively spliced tran-
scripts are from genes encoding a protein phosphat-
ase, myosin light chain, rhoptry neck, a micronemal,
a RNA debranching enzyme, and RNA-binding pro-
teins, amongst others. Because some of these genes
are known to play some role in parasite invasion of
cells, and alternative splicing leads to two protein iso-
forms, there is a potential for this variation to alter
parasite virulence. For example, the one isoform of the
micronemal protein is 769 amino acids long [48] while
the alternative isoform has only 727 amino acids, which
would possibly affect the biology of the parasite e.g. host
cell invasion.
Conclusions
In the current study, we have used approximately 270
million 40 bp paired-end RNA-seq reads to reconstitute
Table 1 Percentage spliced in (PSI) (shown as a fraction) values for some of the alternatively spliced transcripts in the
three clonal strains of Toxoplasma gondii
Gene ID Description ME49 Pru RH
TGME49_053370 Roptry neck 4 L1 homologue 0.41 0.23 0.16
TGME49_008740 microneme protein, putative 0.28 0.31 0.46
TGME49_078510 protein phosphatase 2C, putative 0.71 0.72 0.61
TGME49_038230 serine/threonine protein phosphatase, putative 0.48 0.08 0.09
TGME49_112660 Hypothetical protein 0.50 0.55 0.05
TGME49_097470 Myosin light chain 2, putative 0.34 0.43 0.02
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the level of alternative splicing and accuracy of gene
model prediction of ToxoDB genes. We have discovered
a higher percentage of ToxoDB gene model inaccuracies,
especially in UTR and terminal exon regions, than previ-
ously reported [7] and report on alternative transcript
isoforms as opposed to the single transcript per gene
currently reported in Toxodb. Our results indicate that
RNA-seq is a robust and a relatively cheap method com-
pared to full-length cDNA sequencing that can be used
to annotate Toxoplasma genes and transcripts. However,
as indicated by our results, this method requires high
RNA-seq read coverage. Some of the alternatively
spliced transcripts that we have identified are products
of genes known to play some role in Toxoplasma biology
e.g. attachment to and entry into the host cell. However,
the relevance of each of these alternative transcript iso-
forms in parasite virulence needs further investigation.
Based on our preliminary analysis, some of the tran-
scripts identified are putative long intergenic non-coding
RNAs but further conclusive analysis is necessary. Once
the genome sequencing of the Toxoplasma gondii strains
currently underway is completed, a strategy similar to
that employed for the identification of mouse and zebra-
fish lincRNAs [24,43,49], may be employed to determine
if some of these transcripts are lincRNAs.
Methods
Generation of Toxoplasma mRNA and RNA-sequencing
The Toxoplasma parasite strains (types II PruA7 and
ME49, and type I RH) used in this experiment and itsTable 2 Differential isoform usage between Pru and RH strain
Gene Pru
TGME49_008740 (0,0):3272,(0,1):62,(1,0):14,(1
TGME49_112660 (0,0):580,(0,1):2,(1,0):4,(1,1):6
TGME49_078510 (0,0):2647,(0,1):15,(1,0):15,(1
TGME49_097470 (0,0):1648,(0,1):12,(1,0):22,(1
(0,0):x indicates x reads align to both isoforms but are not used in support of either
from the spliced site, (0,1):x, x reads support the second isoform but not the first, (1
reads supporting both isoforms. Missing values for RH indicate the absence of read
Table 1.maintenance has previously been described [50-53].
Bone marrow derived macrophages (BMDM) obtained
from 25 6–10 weeks old AxB/BxA recombinant inbred
mice and their progenitors (AJ and C57BL/6J) were
seeded in 12 well plates and infected with Toxoplasma
at a multiplicity of infection (MOI) of 1.3 for 8 hours.
Additionally, bone marrow derived macrophages from
C57BL/6J mice were infected with either ME49 or RH
Toxoplasma strains for 24 hours. Total RNA excluding
mirRNA was extracted using the Qiagen RNeasy Plus kit
(Qiagen, USA). Integrity, size distribution and concen-
tration of RNA were then checked using the Agilent
2100 Bioanalyser.
The RNA samples were then processed for high-
throughput sequencing according to standard Illumina
protocols. Briefly, after mRNA pull-down from total
RNA using Dynabeads mRNA Purification Kit (Invitro-
gen), mRNA was fragmented into 200–400 base pair-
long fragments and reverse transcribed into cDNA be-
fore Illumina sequencing adapters were attached to each
end. Samples were barcoded (each barcode was unique
to each sample) and 4 samples were multiplexed in a
single lane on an Illumina sequencing flow cell for
paired end sequencing on an Illumina HiSeq 2000 ma-
chine. Our preliminary RNA-seq experiments of infected
BMDM have shown that 4 samples per lane still results
in enough read density for reliable gene expression ana-
lysis while significantly reducing the cost of sequencing.
The Illumina sequencing pipeline performed primary
data acquisition, determined base calls and calculated
confidence scores.s
RH
,1):275 (0,0):9355,(0,1):99,(1,0):73,(1,1):799
8 (0,0):667,(0,1):23,(1,1):74
,1):178 (0,0):4612,(0,1):18,(1,0):5,(1,1):225
,1):140 (0,0):3796,(0,1):19,(1,1):297
isoform for a variety of reasons including reads aligning to exons far removed
,0):x indicate x reads support the first isoform and not the second (1,1):x, x
s supporting the alternative isoform. The gene descriptions are shown in
Pru
RHR
PK
M
0
1786475 1787339 1790358 1793955 1794820
Genomic coordinate (TGME49_chrII), “+” strand
100
150
0
100
150
200
200
Figure 6 Different isoforms of alternatively spliced transcripts are differentially expressed in diverse Toxoplasma strains. Shown is
RNA-seq read pile up (histogram) on the exons (horizontal bars) of alternative isoforms of TGME49_097470 gene that show differential isoform
usage between a type II (Pru) and a type I (RH) strain. The predominant isoform for the TGME49_097470 gene in RH has identical gene model
and protein sequence as that predicted in ToxoDB.
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For the purposes of de novo transcript assembly, we con-
catenated only the reads obtained from the Pru-infected
bone marrow derived macrophages (27 samples) before
using these in Trinity. Because the RNA-seq reads
obtained above originate from human (the Toxoplasma
parasite used in this experiment was grown on human
foreskin fibroblast), mouse and Toxoplasma genes, we
initially aligned all the reads to mouse (mm9) and
human (hg18) genomes using Bowtie (v0.12.7) and
Tophat (v2.0.0) with the default settings. The resulting
non-aligned reads were considered Toxoplasma reads
and were used in Trinity [18] for transcript assembly.
Trinity is a compilation of 3 distinct programs, each
relying on the result of the preceding one to assemble
full transcripts independent of a reference genome (for
detailed description see Grabherr et al. [18]). Initially
Trinity builds a k-mer (in our case 25 mer) library using
the RNA-seq data, removes error-containing k-mer and
singletons from the library, selects the most abundant k-
mer as a seed and extends the seed on both directions
by finding the next abundant k-mer with a k-1 mer over-
lap with the current contig terminus until the seed can-
not be extended any further. Once a k-mer is used in a
seed, it is removed from the k-mer library (i.e. a k-mer is
used only once). We used Trinity (trinityrnaseq_r2012-
06-08) default settings plus the jaccard clip option and
the maximal heap space.
Next we used the Program to Assemble Spliced Align-
ment (PASA) [29] (PASA-r2011_05_20) with its defaultsettings, to assemble contigs based on the ME49 gen-
ome (7.2 release). PASA aligned the Trinity assembled
contigs to the ME49 genome using the Genome Map-
ping and Alignment Program (GMAP) [53] (gmap-
2007-09-28), filtered invalid contigs (those most likely
arising from sequencing and Trinity assembly errors),
and reconstructed more complete transcripts from the
Trinity contigs by reporting only the single best align-
ment. To achieve this, we constrained our analysis to
Trinity contigs with at least 90% of their length sha-
ring at least 95% similarity with the ME49 genomic
sequence, and for which all the inferred exon-intron
boundaries have canonical splice sites. The use of
PASA to assemble full transcripts based on RNA-seq
data has previously been described [29-31]. Next, we
searched for intersections between the PASA tran-
scripts and ME49 gene coordinates in BEDtools fol-
lowed by alignment of overlapping PASA and ME49
protein sequences to analyze inaccuracies in gene
models.
Assessing alternative splicing and isoform usage
Once we annotated the Toxoplasma genes based on
our PASA alignments, we assembled all the exon
coordinates and chromosomal locations relative to the
ME49 genome in gene transfer file format (gtf ). We
used this file in MISO [47] to quantify the expression
level of, isoform usage of, and pile reads to the alter-
natively spliced genes amongst three Toxoplasma gon-
dii clonal strains.
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Raw short read RNA-seq data have been submitted to
the ToxoDB.Additional files
Additional file 1: Nucleotide sequences of all the PASA transcripts.
Additional file 2: A bed file with the genome coordinates of all the
PASA transcripts.
Additional file 3: Sequences for Trinity contigs having invalid
genome alignment in PASA but aligning to the ME49 genome in
Blast.
Additional file 4: The classes of transcripts obtained at different
stages of our analysis pipeline.
Additional file 5: Blast search results of Trinity contigs rejected in
PASA against ME49 known genes.
Additional file 6: Evidence from ToxoDB showing splice junction
tracks supporting the fusion of TGME49_005240 and
TGME49_005230.
Additional file 7: Identities of PASA transcripts and the ME49 genes
they overlap in addition to the average read coverage.
Additional file 8: A figures showing the correlation between ability
to reconstruct full transcripts of Toxoplasma genes and (A)
expression (represented as reads per kilobase) and (B) RNA-seq
read coverage. We binned the transcripts based on their RPK or raw
read coverage values and we show the fractions of fully assembled
transcripts in each bin (from a total of 2073 fully assembled genes). For
this figure, fully assembled transcripts were defined as those producing
ORFs that matched the ToxoDB proteins both in length and sequence
(2073 total).
Additional file 9: Table showing novel ME49 genes.
Additional file 10: Identities of PASA transcripts supporting
alternative splicing classes and their relative expression values in
27 sequenced samples.Competing interests
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